人工血浆置换治疗对妊娠期急性脂肪肝患者实验室指标及妊娠结局的影响

doi:10.3969/j.issn.1671-7171.2022.08.023

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1143 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To investigate the effect of artificial plasma exchange on laboratory indexes and pregnancy outcome of patients with acute fatty liver during pregnancy. 【Methods】A total of 46 patients with gestational acute fatty liver diagnosed and treated in the First Affiliated Hospital of Naval Medical University from January 2017 to April 2019 were selected and divided into control group (comprehensive treatment, n=23) and observation group (comprehensive treatment combined with artificial plasma exchange, n=23) according to different treatment methods. The liver function index, coagulation index, curative effect and pregnancy outcome were compared between the two groups before and after treatment. 【Results】 Before treatment, the expression levels of direct bilirubin (DBIL), total bilirubin (TBIL), aspartate aminotransferase (AST), alanine aminotransferase (ALT), prothrombin time (PT), platelet count (PLT) and fibrinogen (FIB) were not significantly different between the two groups (P>0.05). Compared with that before treatment, the levels of DBIL, TBIL, AST, ALT and PT decreased and the levels of PLT and FIB increased in the two groups after treatment; The improvement effect and total effective rate of the above indexes in the observation group were better than those in the control group (P<0.05). The incidence of neonatal mild asphyxia and severe asphyxia in the observation group was significantly lower than that in the control group (P<0.05). 【Conclusion】 Artificial plasma exchange therapy can effectively improve the liver function, coagulation function and pregnancy outcome of patients with acute fatty liver during pregnancy, and has certain safety, which is worthy of clinical application.

Key words： Pregnancy Complications Fatty Liver Acute Disease Plasma Exchange/MT Pregnancy Outcome

Received: 17 December 2021

PACS:

R575.5

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MOU Xian-yao
	LI Dan-jie

Cite this article:

MOU Xian-yao,LI Dan-jie. Effect of Artificial Plasma Exchange Therapy on Laboratory Indexes and Pregnancy Outcome in Patients with Acute Fatty Liver During Pregnancy[J]. JOURNAL OF CLINICAL RESEARCH, 2022, 39(8): 1206-1208.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2022.08.023 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2022/V39/I8/1206

[1] NEUMAN R I,HESSELINK E R M,SALEH L,et al. Angiogenic markers are elevated in women with acute fatty liver of pregnancy[J].Ultrasound Obstet Gynecol,2019,56(3):465-466.
[2] 郭咏梅,张雅丽,陈丽. 妊娠期急性脂肪肝临床特点及其不良预后的高危因素分析[J].中国妇幼健康研究,2019,30(9):1085-1090.
[3] WONG M,HILLS F,VOGLER K,et al. Acute fatty liver of pregnancy from 18 weeks' gestation[J].Hepatology,2020,71(6):2167-2169.
[4] 古伟光,池锐彬. 血浆置换救治妊娠期急性脂肪肝一例并文献复习[J].海南医学,2019,30(24):3256-3258.
[5] 姜明建,范蔚芳,林淑媛. 人工肝血浆置换联合血液滤过对妊娠中晚期重症肝病患者临床指标和生存率的影响[J].肝脏,2018,23(10):46-48.
[6] 曹泽毅. 中华妇产科学[M]. 北京:人民卫生出版社,2006.
[7] 朱宝剑. 人工肝血浆置换治疗妊娠期急性脂肪肝疗效观察[J].中国医药,2010,5(1):67-68.
[8] 戴小财,刘迪,刘青. 血浆置换联合连续性血液净化治疗肝衰竭患者的临床疗效[J].医学临床研究,2019,36(9):1715-1717.
[9] 张文凤. 人工肝血浆置换联合分子吸附系统对重症肝炎肝硬化患者血清内毒素、细胞因子清除和肝功能的影响[J].标记免疫分析与临床,2018,140(6):113-116.
[10] 张璐璐,王倩,杨萍,等. 妊娠期急性脂肪肝母婴不良结局15例分析[J].青岛大学医学院学报,2018,54(1):82-84.
[11] 杨田军,朱春艳,范晓钦,等. 妊娠急性脂肪肝患者实验室指标演变特点及血浆置换对这些参数的影响[J].中国中西医结合急救杂志,2018,25(6):620-624.
[12] 陈科第,杨道锋,陈广. 妊娠期急性脂肪肝12例临床分析[J].临床肝胆病杂志,2018,34(3):558-561.
[13] 周敏,罗小东,杨洋. 54例妊娠急性脂肪肝患者临床特点和实验室指标变化分析[J].中华肝脏病杂志,2019,27(8):638-642.
[14] 许仁美,童武华,过勇杰. 即时或延时终止妊娠对妊娠期急性脂肪肝患者妊娠结局的影响[J].中国妇幼保健,2019,34(19):4427-4429.